Pathology News

UKNEQAS CPT Annual Participant Meeting 2025
2025-11-04 | The Parkgate Hotel, Cardiff, Westgate Street, Cardiff, CF10 1DA, United Kingdom
0000Days00Hrs00Min00SecFuture Innovations and Investments
Leading The Future by Creating It
This event will centre on the future of Cellular Pathology, exploring innovations, technological advancements, and the latest regulatory changes shaping the field. Key discussions will highlight how these developments impact laboratory operations and the workforce. In addition, breakout sessions and Q&A opportunities with expert coordinators will provide practical insights into addressing everyday challenges faced in the field.
Register Now

6th NHS Pathology Conference: Improving NHS diagnostics
2025-11-04
0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences
Current Landscape:
Pathology is increasingly becoming a collaborative and interdisciplinary field, with a strong focus on integrating innovative technologies and practices. This shift is essential to meet the growing demands of modern healthcare, where the challenges of disease management, diagnostics, and treatment require cutting-edge solutions and cross-border cooperation.
Timeliness of Event:
This conference is especially relevant as healthcare systems face the dual pressures of managing current patient demands and integrating new technologies into pathology services. With the rapid evolution of healthcare needs and the advent of new diagnostic tools, the event provides a timely platform for discussing how to optimize pathology services across regions and disciplines.
Register Now

Key Subjects:

Pathology Beyond Borders: Integrating Innovation and Collaboration Across Disciplines: Exploring how international collaboration and innovative approaches are reshaping pathology, breaking down silos, and improving global health outcomes.
MES Procurement Approach: A detailed discussion on the strategies and best practices for procuring Managed Equipment Services (MES), ensuring efficient and cost-effective delivery of pathology services.
Fire Panel Discussion: Cross-region Learnings: A dynamic exchange of insights from various regional pathology networks, focusing on shared challenges and solutions, operational strategies, and enhancing cross-region collaboration.
Pathology 2.0: Pioneering Tech Advancements Shaping Future Services: Delving into the latest technological innovations such as AI, digital pathology, and next-generation sequencing that are revolutionising pathology services and setting the stage for the future.
Local Pathology Networks: Examining the role of local pathology networks in managing demand and capacity, ensuring quality service delivery, and optimising resource utilisation.
Managing Demand and Capacity: Addressing the operational challenges in pathology, including strategies for efficient demand management and capacity planning to meet the needs of modern healthcare.

Why Attend:
Attendees will gain valuable insights into the future of pathology, with a focus on integrating innovative technologies, optimising procurement processes, and enhancing cross-region collaboration. This event is an essential opportunity for professionals to learn from experts, share best practices, and explore new approaches to managing the growing complexities of pathology services.

ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
2025-10-28 15:30 - 16:30 UTC | Online
0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients, at the right moment, with the right data.
With the launch of Proscia Aperture™, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies.
Clinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams.
And for everyone attending, the Partner Expo will feature breakthroughs in pathology AI, next-generation infrastructure, and enterprise solutions—delivered by the strongest ecosystem in the industry.
Register Now

TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
2025-10-27 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Dr Tapabrata (Rohan) Chakraborty from UCL, London, UK.
Abstract
For AI to be trusted for use in high risk applications like healthcare, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance.
Register NowBio
Rohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.

AISight Dx Digital Pathology Platform: Live Deep Dive
2025-10-23 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale.
In this webinar, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale, including seamless slide management, flexible collaboration, and interoperability across a broad range of whole-slide imaging scanners, and will explain what PCCP means for ongoing updates and customer value.
You’ll also see a live demonstration with case-based examples covering slide navigation, AISight Live for synchronous and asynchronous collaboration, annotation tools, and the caselist dashboard.
What you’ll learn

What FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap
How pathologists and lab leaders can standardize workflows, collaborate across teams, and stay ready for future feature updates enabled under the PCCP
Live demo: lightning-fast slide navigation and manipulation, measurements and annotations, real-time and asynchronous collaboration with AISight Live, case list triage, search, filters, and workflow handoffs

Register Now

Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
2025-10-21 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!
SummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition, severely hampering development of therapeutic interventions. Using genomics, spatial transcriptomics, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia, angiogenic and inflamed endothelial cell profiles, reactive astrocytes, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes.
Learning Objectives
Understand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases
Understand how HALO AI can be used to identify unique cell populations with complex, varied shapes
Explore how genomic data can be validated using histologic images analysis

Register NowPresenterJonathan Cherry, PhD
Research Health Scientist
VA Boston Healthcare System
Director, Digital Pathology Core & Research Neuropathologist
Boston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center
Assistant Professor of Pathology and Laboratory Medicine
Boston University Avedisian & Chobanian School of Medicine
Dr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008, earned his doctoral degree in Pathology from the University of Rochester in 2015, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.
Dr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.
Dr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease, chronic traumatic encephalopathy, frontotemporal lobar degeneration, motor neuron diseases, and others.

Conference on Artificial Intelligence in Medical Imaging
2025-10-20 - 2025-10-21 | University of California, Irvine, CA, United States
0000Days00Hrs00Min00Sec

CMIMI is now SIIM-CAIMI!

New name. Sharper focus. Same cutting-edge research.

Unparalleled Research Focus

In-depth talks from top AI and imaging research centers with live Q&A
A space to test ideas, challenge norms, and refine AI approaches
Accepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine

Immersive Scientific Discussions

Deep dives into methods, results, and clinical relevance
Discussions on AI bias, model generalizability, and regulatory considerations
Case study-driven conversations connecting theory to real-world impact

A Multidisciplinary Community

Connect with researchers, clinicians, and industry leaders in an intimate setting
Build partnerships across academia and industry
Be part of a welcoming environment for trainees and early-career professionals

AI in Action – From Research to Real-World Applications

Cutting-edge model development for accuracy and explainability
Real-world AI integration in imaging workflows
Ethics and regulation for responsible AI deployment

Register Now

ESMO Congress 2025
2025-10-17 - 2025-10-21 | Messe Berlin, Messedamm 22, Berlin, 14055, Germany
0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care.
You will be able to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis, treatment and survivorship.
A comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients.
Learning objectives

To review and be updated on prevention, screening and early diagnosis of cancer
To be updated on the latest breakthroughs in basic science, translational and clinical cancer research
To analyze and understand the clinical perspective of the scientific advances in cancer biology, diagnostics, and new treatments
To learn the optimal roles of novel diagnostics and treatments for patients with cancer

Register NowMeet Our Partner

Meet Mindpeak, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency.
Catch them at ESMO 2025 — Booth #4010.
Discover how AI is reshaping the future of oncology.

Accreditation
ESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details .
Disclaimer
ESMO is a scientific and professional, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs, invited speakers, presenters, members or any other contributor, formally or informally, which might cause offence or be perceived as being biased.
The experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.

Masterclass Webinar: Admin and Metadata Options in HALO Link
2025-10-16 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecLearn how to maximize the efficiency, customization, and data management capabilities of your HALO Link deployments!
SummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency, customization, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard, highlighting tools for managing users, groups, and permissions, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.

The webinar will also dive into metadata management, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments, this session will equip administrators with practical strategies to tailor HALO Link to their needs, reduce administrative burden, and empower users to work more efficiently.

Learning Objectives
Learn about all the functionality in the current Admin Dashboard in HALO Link
Learn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing
Learn about tools to manage users, permissions, and user groups
Learn about creating and managing system metadata fields

Register NowPresentKat Latimer
HALO Link Associate Product Manager
Indica Labs
Kat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression. In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience.

Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
2025-10-15 15:00 - 16:00 (Europe/Paris) | Online
0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET, 2 PM BST, and 9 AM EST.
Spatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions, these tools reveal previously hidden molecular characteristics, allow for more granular tissue classification, and address challenges posed by compromised sample quality.
Learning Objectives:

Understand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.
Learn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.
Compare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.

Register NowSpeaker:
Prof. Felix Sahm
Prof. Dr. Dr. med. Felix Sahm, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology
University of Heidelberg
An internationally recognized expert in brain tumor diagnostics, he has authored over 500 publications, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.

TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
2025-10-13 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
The next seminar will take place on Monday, 13 October, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC, The Netherlands, who will be joining online.
Abstract
The integration of diverse data types—such as histopathology, radiology, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization, model generalization, and clinical translation.
Register NowBio
Dr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC, where she leads research at the intersection of deep learning, digital pathology, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.

2nd Annual Congress of Asian Society of Digital Pathology
2025-10-10 - 2025-10-12 | JW Marriott Mumbai Sahar, Mumbai, India
0000Days00Hrs00Min00SecPixels to Practice: Advancing Digital Pathology in Asia
What to Expect at ASDP 2025Where Pathology Meets AI: The Future of Diagnostics Begins
The Asian Society of Digital Pathology (ASDP) Conference 2025 will serve as a pivotal meeting point for leaders in medicine, artificial intelligence, and industry. This event brings together a diverse community of clinicians, researchers, technologists, and decision-makers who are shaping the future of diagnostic practice.— and innovation into impact.
Conference Highlights:

Visionary keynote presentations from internationally recognised pioneers in AI and digital pathology
Groundbreaking research from leading laboratories and academic institutions
Live demonstrations showcasing AI tools that are transforming diagnostic workflows
Expert-led panels addressing regulatory pathways and clinical adoption
Networking opportunities with global experts, innovators, and healthcare policymakers

Who Should Attend:
From clinicians and computational scientists to regulatory experts and healthcare leaders, ASDP 2025 offers valuable insights and practical knowledge for anyone driving progress in digital diagnostics. This is where knowledge translates into innovation — and innovation into impact.
Register Now

Pathology Vision 2025
2025-10-05 - 2025-10-07 | Manchester Grand Hyatt, San Diego, United States
0000Days00Hrs00Min00SecCONNECT WITH INDUSTRY LEADERS,
AND THE FUTURE.
Pathology Visions brings together 800+ experts and peers across the field of digital pathology to address real-world, practical applications of digital pathology today, as well as the future of the field through new technologies and developments.
If you are a clinician or a researcher, a technician or a trainee, PathVisions is the place for you.
Your industry is changing. Are you keeping up?
Register NowLook for SIIM at the Digital Pathology Association (DPA)’s Pathology Visions 2025.
Attend the SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: form Basic Science to Pragmatic Approaches to Pixels on October 5 and/or come to Booth #103 for a demo of our Virtual Hospital SIIMulator (VHS), an online sandbox for DICOM, HL7, FHIR.
SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: from Basic Science to Pragmatic Approaches to PixelsSun, Oct 5
11:00AM – 12:00PM PT
Seaport Ballroom

The Challenges of Digital Pathology Conversion: Transitioning from traditional practices to digital pathology focused around the DICOM standard presents unique challenges, from system integration to data management. We will discuss these challenges in detail and introduce SIIM’s tools and resources to help pathologists and institutions navigate this conversion. Learn about best practices for overcoming common obstacles, optimizing workflows, and ensuring smooth implementation.
The Breadth of Research in Pathology Imaging at SIIM: SIIM is at the forefront of imaging informatics research, including in the field of pathology, based on successes of imaging standardization in radiology. This segment will explore SIIM’s extensive research efforts that are driving innovation in pathology imaging. We will showcase studies, collaborations, and advancements that will shape the future of digital pathology, with a focus on imaging technologies and their application in diagnostic workflows.
SIIM’s Commitment to Strategic Technical Leadership and Education in Digital Pathology: As part of our mission to empower imaging professionals, SIIM can provide strategic leadership and education in digital pathology imaging informatics. This section will highlight our ongoing initiatives to advance technical expertise, provide training programs, and support the integration of emerging technologies into pathology practice. Learn how SIIM is paving the way for pathologists.

Adapt or Fall Behind: Why the Best Labs Use AI
2025-10-01 15:00 - 16:00 (Europe/London) | Online
0000Days00Hrs00Min00SecArtificial intelligence is reshaping the lab landscape—not in the future, but now. In this webinar, we’ll explore why adopting AI is no longer optional for modern labs and share real-world insights from clinical leaders who have already taken the leap. Learn how labs in anatomic pathology, microbiology, cytology, and more are using AI to impact their staff and the patients they serve—and the lessons they’ve learned along the way.
Presenter

Dr. Chen is a leader in digital and computational pathology, holding a medical degree from the Mayo Clinic Alix School of Medicine and a master’s in Global Medicine from USC. She completed her anatomic pathology residency at Brigham and Women’s Hospital and an NIH/NCI postdoctoral fellowship in computational pathology at Harvard Medical School and Mass General Brigham. Before joining Techcyte, Dr. Chen led digital pathology initiatives at a cancer pharmaceutical company, driving advancements in AI-powered diagnostics.

Register Now

Precision Medicine: Redefining the Future of Healthcare
2025-09-30 - 2025-10-01 | QEII Centre, London, UK, London, United Kingdom
0000Days00Hrs00Min00Sec

Delivering Personalized Treatments

Join Biomarkers & Precision Medicine UK, an immersive event now in its 20th year, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies, pioneering biotech firms & startups, and leading academic & healthcare institutions, all contributing to various therapeutic areas and stages of drug development, clinical trials, and precision patient treatments.

What is Biomarkers & Precision MedicineTargeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments.
Are you ready to participate in this shared opportunity? Do you have the knowledge, strategy, tools and connections in place?
Precision Medicine provides the platform for you to learn, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma, biotech, academia and healthcare.
Biomarkers & Precision Medicine UK, takes place on September 30-1 October in London, UK. Running across two full days, with 16 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market
Register Now

Why attend?

Expand your knowledge
Let subject specialists take you further and deeper.
With comprehensive learning in oncology, neuroscience and key complementary areas.
Build the partnerships you need
Identify, meet and collaborate with the people your strategy requires.
Start working with those who share your goals with 200 hours of pre-arranged 1-2-1s.
Join the conversation
Meet like-minded peers, expand your network and engage in interdisciplinary discussion on the latest thinking and practice.
See what’s in the pipeline
Our events are where innovations land.
Be at the showcase and meet the people behind technologies to give you the edge.
Understand the competitive landscape
Learn what others in your field are doing.
Evaluate their successes (and failures) and set your own benchmarks.
Harness AI & machine learning
AI & machine-learning tools will be critical in unlocking growth.
See the technology in action and speak to those who can help you implement it.

Evaluation of HER2-Low and Ultralow Status of Advanced Breast Carcinomas
2025-09-29 14:00 - 15:00 (Europe/London) | Online
0000Days00Hrs00Min00SecJoin this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies.
The aim of the study was to:

compare the outcome of HER2 scoring using conventional microscopy, digital pathology, and AI.
assess changes in HER2-low status in core biopsies, matching operation specimens, and their distant metastases.

Register for the webinar to learn more about the findings and how AI can help determine a more accurate HER2-low status, providing an exact percentage of each HER2 score within seconds with high accuracy.
Who should join?

Pathologists involved in biomarker testing
Oncologists relying on HER2-low status in treatment decisions
Anyone involved in breast cancer diagnostics or therapeutic decision-making
Anyone interested in using or developing AI models for image analysis in digital pathology

Register NowSpeakersAnikó Kovács, MD, PhD
Associate Professor, Pathologist, and Lecturer
Sahlgrenska University Hospital

Has worked in research in Sweden for the past 23 years
Breast cancer research at the Leicester University in the UK
Research background also in Japan (Kitasato University) and Hungary

Rute Pedrosa, PhD
Senior Field Application Scientist
Aiforia Technologies

Has worked at Aiforia for 2.5 years
PhD at Erasmus University Rotterdam, focusing on the pathogenesis of brain metastatic disease

Digital Diagnostic Summit 2025
2025-09-28 - 2025-09-30 | The St. Regis Deer Valley, Park City, United States
0000Days00Hrs00Min00Sec

Innovation in Action

Moving the needle from theory to actual, implemented, and viable digital pathology

Nestled at the base of the breathtaking Wasatch Mountains in the picturesque Park City, Utah, the Digital Diagnostic Summit stands as a beacon for innovation and adoption in digital pathology. Here, leading experts converge in a unique blend of professional collaboration and unconventional networking that go beyond the conference walls and into immersive experiences.

Register NowExecutive Innovation RoundtableAdam Cole, MD
Founder & CSO, TruCore Pathology Group
Giovanni Lujan, MD
Director, Digital and Computational Pathology, The Ohio State University Wexner Medical Center
Melissa Alexander, PhD, MD
Regional Medical Director, AstraZeneca
Jill Stefanelli
President and CEO, Modella AI
Jonathan Anderson
National Director of Laboratory Operations, Solaris
Matthew Leavitt, MD
Founder, DDx Foundation
Michael Martinak, MBA, SCT (ASCP)
Executive Director Anatomic Pathology, Quest Diagnostics | AmeriPath | Dermpath Diagnostics
Orly Ardon, PhD, MBA
Director of Digital Pathology Operations, Memorial Sloan Kettering Cancer Center
Wes Bernhardt
Managing Partner, OnePath Diagnostics

The ERS Congress 2025
2025-09-27 - 2025-10-01
0000Days00Hrs00Min00SecGet all the latest updates in respiratory medicine and science at the ERS Congress 2025.
This year’s theme is ‘Respiratory health around the globe’.

The ERS Congress is the world’s largest and most influential event in respiratory medicine, bringing together leading clinicians, researchers, and healthcare professionals to explore the latest advances in the field. With a rich and diverse programme covering everything from airway diseases and sleep disorders to thoracic oncology and critical care, the congress offers valuable learning opportunities for professionals at all career stages.
Attendees can benefit from expert-led symposia, workshops, and skills training. The congress also emphasizes patient involvement, with strong collaboration from the European Lung Foundation.

Register NowMeet our partner

NSH Histotechnology Convention
2025-09-26 - 2025-09-30 | The Long Beach Convention Center, Long Beach, CA, United States
0000Days00Hrs00Min00SecExperience 4 days of cutting-edge research, expert-led workshops, and hands-on histology training in developing specialties. Explore the largest histology-focused Exhibit Hall in America, featuring top industry vendors previewing equipment, supplies, and services for your lab. And create a network of histology experts that will continue to support you when you return to your lab and help to advance your career.
Who Should Attend

Histotechs/Cytotechs in Clinical, Veterinary, and Research Settings
Pathologists and Pathology Assistants
Lab Supervisors/Managers
Scientists / Investigators / Researchers
Students interested in a Histology Career
Sample Management Technicians
Study Directors/Monitors
Lab Aids that Assist with Study Set-Ups
Anyone involved in the collection, processing, and evaluation of human and animal tissue samples

Register Now100+ HOURS OF TRAINING

Learning Labs: hands on trainings that provide the opportunity for attendees to observe and practice skills with lab equipment and reagents
Topic Roundtables: connect one-on-one with peers over your shared interests in histology
Express Talks: 15-minute lectures exploring a troubleshooting tip, management tool or technique demonstration
Workshops: 60-minute lectures with interactive Q&A
Scientific Posters: explore new research and findings from your fellow colleagues and practitioners in the field.

Prognostic Risk Profiling from Digitized H&E: a look at new international performances of an AI model for breast cancer
2025-09-25 17:00 - 18:00 (Europe/London) | Online
0000Days00Hrs00Min00SecRegister using the link, available below!
Join expert pathologist, Magali Lacroix-Triki, and Owkin senior data scientist, Valentin Guary, as they present new findings on RlapsRisk® BC, an innovative AI-driven solution for breast cancer recurrence risk assessment from digital pathology slides. This webinar will showcase comprehensive data comparing RlapsRisk® BC’s performance against traditional clinical scores and established molecular tests. Our panel will discuss how this revolutionary tool helps to enhance prognostic accuracy and has the potential to transform treatment decision-making in breast cancer care.
Attendees will gain valuable insights into:
▪ The impact of AI-powered digital pathology solutions for outcome and prognostic prediction
▪ Latest performance results from ongoing studies
▪ First comparisons with current testing approaches
▪ Real-world implementation experiences
▪ Potential impact on treatment planning and patient care
RlapsRisk® BC is under development and not for clinical use. It is not FDA cleared or approved in the USA. RlapsRisk® BC is developed within the PortrAIt consortium, a french consortium financed by the government within the framework of France 2030 and by the European Union – Next Generation EU within the framework of the France Relance Plan.
Register Here

BSTP – ESTP Congress
2025-09-23 - 2025-09-26 | Hilton Deansgate Hotel, Manchester
0000Days00Hrs00Min00SecThe 2nd Joint BSTP/ESTP Toxicologic Pathology Congress will be held in Manchester, UK and will take place from 23rd – 26th of September 2025.
The British Society of Toxicologic Pathology (BSTP) and the European Society of Toxicologic Pathology (ESTP) are excited to announce the 2nd Joint BSTP/ESTP Toxicologic Pathology Congress, titled “Carcinogenicity in the 21st Century: Challenges of New Methodologies, Strategies, and Their Impact on Pathologists.”
Register NowThe Scientific Organizing Committee, made up of nationally and internationally recognized experts, has already started putting together an exciting scientific program after their first meeting in May 2024. The congress will cover key topics like new methodologies for carcinogenicity testing in agrochemicals and pharmaceuticals, predicting carcinogenic potential early on, assessing new modality drugs, understanding the human relevance of findings in carcinogenicity studies, and risk assessment. Expect a mix of plenary lectures, original scientific presentations, interactive case discussions, and poster sessions. Alongside this, there’ll be an IATP symposium and an ESTP expert workshop focused on the female reproductive system. A trade exhibition will showcase the latest equipment, technologies, and services. For a bit of fun, don’t miss the welcome reception on 23rd September 2025 and the congress dinner on 25th September.

28th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI 2025)
2025-09-23 - 2025-09-27 | Daejeon Convention Center, Daejeon, Korea, Republic of
0000Days00Hrs00Min00SecThe 28th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI 2025) will take place from Tuesday, September 23 to Saturday, September 27, 2025, in Daejeon, Republic of Korea. This marks a significant milestone, as it will be the first time the MICCAI conference is hosted in Korea.
The MICCAI 2025 Organising Committee, together with the local host team in South Korea, has been preparing for this event over several years with great care and enthusiasm. Their collective efforts are focused on ensuring that MICCAI 2025 provides an engaging, inclusive, and high-quality experience for all attendees.
As one of the premier gatherings in the field, the MICCAI annual conference consistently attracts a global community of leading biomedical scientists, engineers, and clinicians working at the forefront of medical imaging and computer-assisted interventions. The conference will feature three days of core scientific content, including oral presentations, poster sessions, and keynote lectures.
Surrounding the main conference are satellite events — workshops, tutorials, and challenges — held on the days before and after the main program. These offer in-depth engagement on specialized topics and are a vital part of the MICCAI experience. Attendees will also benefit from industrial sessions and exhibitions, providing valuable opportunities for interaction between academia and industry.
Additionally, the Student Board and Women in MICCAI Board will enrich the program through a variety of social and networking events, ensuring a vibrant and supportive environment for all participants.
All members of the MICCAI community are warmly invited to join the conference in Daejeon in 2025. It promises to be a memorable and inspiring event, bringing together experts from around the world to share knowledge, foster collaboration, and shape the future of medical image computing and computer-assisted intervention.
Register Now

National Imaging Informatics Course - Fall 2025
2025-09-22 - 2025-09-26 | Online
0000Days00Hrs00Min00SecLearn the fundamentals of Imaging Informatics.

National Imaging Informatics Course (NIIC), Borne out of our collaboration with the RSNA + DPA, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics.

Get working knowledge fast with SIIM’s National Imaging Informatics Course (NIIC)

The National Imaging Informatics Course (NIIC) is an accelerated, week-long online experience for imaging informaticists seeking to better leverage their expertise towards a broader, more holistic engagement within the field.
Borne out of our collaboration with the RSNA and DPA, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics – in order to create enduring engagement and innovation within the field.
Participants develop a well more well-rounded understanding of the field, demystify business cases and become more confident, effective and valuable in the fast-changing medical and healthcare fields – plus earn up to 20 hours of SIIM IIP Credits doing so!
It is the perfect opportunity to introduce non-radiology professionals to the field of imaging informatics, gain relevant understanding of how medical/healthcare systems work in total and impact how patients are cared for every day.
This NIIC Term is made possible by a partnership between the Radiological Society of North America (RSNA), the Digital Pathology Association (DPA) and the Society for Imaging Informatics in Medicine (SIIM); and initially funded by a grant from the Association of University Radiologists (AUR), this course has been developed by a team of faculty comprised of experts in imaging informatics from around the world.

Register Now

Imaging Informatics for All

NIIC is open to anyone across the healthcare enterprise seeking to gain a baseline understanding of imaging informatics, advance cross-functional skillsets and invest in their career goals.

Individual professionals
Practicing physicians
Institutions
Trainees at all levels
Faculty
IT experts
Industry partners
and more!

Key Features

NIIC’s specialized curriculum is packed with relevant exercises (and tips) across the imaging informatics spectrum that are essential to modern medicine/healthcare including:

Clinical workflow
Hardware/software/networking requirements
Standards
Patient-centric radiology
PACS archives
Business aspects
Hot topics: AI, mission-learning, data science, and 3D printing

The course is efficiently structured with intellectually stimulating pre-work and well-thought-out agendas plus an ample 3-month window to complete homework assignments.

IBMS Congress 2025
2025-09-22 - 2025-09-25
0000Days00Hrs00Min00SecLinking learning to the laboratory
The IBMS Congress 2025 is set to be one of the most significant gatherings for biomedical and laboratory professionals, bringing together experts, researchers, and industry leaders to discuss the latest advancements in laboratory medicine, diagnostics, and pathology.
Organized by the Institute of Biomedical Science (IBMS), the congress will offer a comprehensive program featuring cutting-edge research, keynote presentations, workshops, and an extensive exhibition showcasing the latest technologies and solutions in the field.
IBMS Congress will provide an invaluable platform for knowledge exchange, professional development, and networking. Attendees will have the opportunity to engage with leading voices in biomedical science, explore innovations in digital pathology and AI-driven diagnostics, and participate in discussions shaping the future of laboratory medicine. Whether you’re looking to expand your expertise, discover new research, or connect with industry peers, IBMS Congress 2025 promises to be an unmissable event for the global biomedical science community.
Register Now
Whether you are a first-time attendee or a long-standing participant, I am delighted to see our vibrant community come together once again to connect, collaborate, and innovate. This year’s Congress promises to be our most comprehensive yet, offering a wealth of knowledge and inspiration through a diverse range of educational programmes, cutting edge exhibitions, and unparalleled networking opportunities.

Meet Our PartnersMeet Source LDPath at Stand 720
Visit Philips on Stand F1,
where you can connect with our experts and discover our cutting-edge digital pathology solutions – designed to improve diagnostics and simplify workflows.

Intro to HALO®, HALO AI, and HALO Link 4.2
2025-09-18 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecLearn about the exciting new features in the 4.2 versions of HALO, HALO AI, and HALO Link!
SummaryIn this webinar, Indica Labs will explore the new features and functionalities in HALO, HALO AI, and HALO Link 4.2 designed to enhance performance, streamline workflows, and expand analytical capabilities. In HALO 4.2, new annotation tools such as a multi-select feature and improved annotation management, including batch annotation import and rename, boost efficiency. Also, object data is moved out from the database into optimized parquet files, significantly improving load times and overall system performance.
HALO AI 4.2 offers channel-invariant pretrained models that streamline nuclear and cell segmentation by leveraging all fluorescent channels, and multiple membrane markers can now be selected when further training the pretrained membrane segmentation model. Version 4.2 also brings an updated AI annotation tool that is smaller, faster, and optimized for pathology data, delivering a smoother annotation experience. Users now have greater control over model training with adjustable hyperparameters, including learning rates and class weights.

In version 4.2, HALO Link now supports viewing Z-stacks on brightfield images. The latest version also introduces a Diagnostic Monitor add-on to help administrators troubleshoot performance issues with image loading. For those looking for additional ergonomics options, integration with the 3D Connexion SpaceMouse is now available. Finally, both HALO and HALO Link 4.2 support the use of third-party AI apps, enabling models developed by users outside of HALO or by external vendors to be launched and viewed within the platforms.

Learning Objectives
Learn about third party AI Analysis support through API
Learn about new annotation tools and object data storage in HALO
Learn about streamlined nuclear and membrane segmentation using channel invariant pretrained models
Learn about using the 3D Connexion SpaceMouse for more ergonomic slide navigation in HALO Link

Register NowPresenterDr. Noemi Kedei
Director of Product, Life Sciences
Indica Labs
Noemi Kedei earned an MD degree from University Medical School of Debrecen, Hungary. She did her postdoctoral training and worked later as a staff scientist in the Laboratory of Cancer Biology and Genetics, NCI. Her research focused on identifying mechanisms involved in the differential effects of natural compounds and their engineered derivatives acting on protein kinase Cs (PKCs), validated targets for anti-cancer treatment. In 2018 she joined the Collaborative Protein Technology Resources (OSTR, CCR, NCI) core facility to implement a variety of spatial protein and transcriptomics technologies, and lead related operations as services to NCI investigators. Noemi provided the expertise for development of project based customized antibody protein panels for detection of 40-60 protein targets at single cell level in tissue sections using the CODEX/Phenocycler fusion technology, and ensured optimal and efficient instrument use. In addition, she advised and supported users on tools for quantitative image analysis combining different AI-enabled HALO modules and NCI developed pipelines for downstream analysis. Noemi joined Indica Labs as Director of Product – Life Sciences in May, 2025.

Future-ready Pathology: Embracing digital transformation for improved patient care
2025-09-17 15:00 - 16:00 UTC
0000Days00Hrs00Min00SecRegister using the link, available below!
Two leading European hospital networks—Hospital Universitario Quirónsalud Madrid and Groupe Hospitalier Paris Saint-Joseph/Hôpital Marie-Lannelongue—shared how they transformed pathology services through digital innovation in collaboration with Philips. The webinar highlights how cloud infrastructure enables scalable, compliant storage; AI enhances diagnostic speed and quality; and integrated diagnostics are bringing pathology and radiology together for more connected, patient-centered care.
Learning Objectives:

Understand how digital pathology enables subspecialty-based collaboration across hospitals, enhancing diagnostic quality and operational flexibility.
Explore how AI tools support lesion detection and quantification to improve diagnostic efficiency and accuracy.
Learn how end-to-end support from Philips—including infrastructure planning and cloud integration—facilitates scalable digital transformation.
Recognize the role of cloud-based storage and intelligent retention policies in streamlining data management and enabling integrated diagnostics.

REGISTER HERE

Can AI Predict Patient Outcomes in Ovarian Cancer?
2025-09-16 13:00 - 14:00 (Europe/London) | Online
0000Days00Hrs00Min00SecExperimental image-based AI models are very good at extracting new information from standard H&E pathology slides. However, the biological interpretation of these novel findings is a challenge. In this webinar, Dr. Anna Laury, Clinical Researcher at the University of Helsinki, will explain how they used scanned H&E slides of high-grade serous carcinoma of the tube/ovary (HGSC) together with spatially resolved transcriptomics to explore whether AI findings actually represent biological differences in these tumors.
High-grade serous carcinoma of the tube/ovary (HGSC) is characterized by aggressive behavior, chemotherapy resistance, and low 5-year survival, but also exhibits striking variability in outcome. Our understanding of this disease is limited, partly due to considerable tumor heterogeneity, and predicting any individual patient’s response to therapy is challenging.
Dr. Laury’s team used Aiforia® Create to train an AI model to predict patient outcome in HGSC by identifying tumor regions that are highly associated with outcome status. The tumor regions identified by the AI model are currently indistinguishable by pathologists. They then used spatially resolved transcriptomics to profile these AI-identified tumor regions and identify molecular features related to disease outcome.
Register for the webinar to hear more about this proof-of-concept study, which shows that AI-guided spatial transcriptomic analysis improves recognition of biologic features relevant to patient outcomes.
Register NowSpeakersAnna Laury, MD, PhD
Clinical Researcher
University of Helsinki
Dr. Laury is a clinical researcher at the University of Helsinki. She received her medical degree from the University of California, Los Angeles and pathology training at Brigham & Women’s Hospital. Her clinical interests include women’s and perinatal pathology, and her research is currently focused on the development and progression of tubo-ovarian serous carcinoma.
Darshan Kumar, PhD
Director of the Global FAS team
Aiforia Technologies
Darshan Kumar has worked at Aiforia for over four years as a Customer Success Manager and Scientist. He currently leads the global team of Field Application Scientists. He did his PhD research in cell and molecular biology at the University of Helsinki and has a master’s in Biomedical Sciences from Leiden University.

CAP25 The Pathologists' Meeting
2025-09-13 - 2025-09-16 | Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL, 32821, United States
0000Days00Hrs00Min00SecThe Pathologists’ Meeting is where the science meets the soul of what we do. Where your expertise is celebrated, knowledge flows, and connections spark all around you. At CAP25 every lecture or hallway conversation reminds you of why we chose this specialty in the first place. Because it’s more than an annual meeting; it’s your community.
It’s Where You Belong!
CAP25 is where science converges with the soul of pathology.It’s more than an event—it’s a community where your passion and expertise are uplifted, knowledge flows freely, and every interaction reawakens why we chose this path.
Why it matters:

Each lecture and hallway chat reminds you of that core sense of purpose.
It’s a place for celebration: your work, your field, your network.
CAP25 isn’t just another conference—it’s a homecoming for the pathology community.

Whether you’re hungry for insight, craving connection, or just want to reconnect with your “why,” CAP25 is the place where community, culture, and cutting‑edge science come together.
Register Now

Mastering Image Quality Control with AIRA Matrix
2025-09-09 16:00 - 17:00 (Europe/London) | Online
Artificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions, highlight differentiating features, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors, streamline processes, and support more reliable outcomes.
The session will be led by Marco Comianos, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales, marketing, and commercial leadership across healthcare and life sciences, including roles in medical imaging, EMR, and healthcare AI. Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs.
Learning Objectives

Why addressing quality control with AI matters
How Aira Matrix differentiates itself in the market
Key product features and their impact on efficiency
A live demo of the platform in action

Register Now

37th European Congress of Pathology
2025-09-06 - 2025-09-10 | Austria Center Vienna, Vienna, Austria
0000Days00Hrs00Min00Sec

Key facts about the upcoming congress

Event Information:
The 37th European Congress of Pathology (ECP) will be held at the Austria Center Vienna (ACV) from 6–10 September 2025, gathering over 5,000 international experts in pathology and related fields.
Theme and Programme:
The congress motto, “ECP Vienna – Tradition Meets Future,” emphasizes the advancements in pathology and its role in modern diagnostics and therapies. The programme will include keynote lectures, symposia and various other session formats led by renowned experts, reflecting on dynamic developments in the field.
Focus on Education and Training:
Dedicated sessions for trainees will highlight cutting-edge advancements and demonstrate the ESP’s commitment to shaping the future of pathology.
Venue and Accessibility:
The Austria Center Vienna, Austria’s largest congress center, is ideally located in the UNO City, with easy access to the airport, hotels, and city attractions.

Register Now

Why You Should Attend the Congress

Take advantage of numerous opportunities to showcase your company and research during the congress:

Industry Sponsored Symposia
Technical Exhibition
Various online & on-site items

The Austria Center Vienna (ACV) is the largest congress center in Austria. Located approx. 22 km from the airport, this modern venue offers an overall event space of 22,000 sqm on 5 different levels.
The ESP is seeking approval from the European Accreditation Council for Continuing Medical Education (EACCME) to provide CME credits for the scientific programme of the congress.
